Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy.

Autor: Stoodley J; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK.; MDUK Oxford Neuromuscular Centre, Oxford, UK., Miraz DS; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK.; MDUK Oxford Neuromuscular Centre, Oxford, UK., Jad Y; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK.; MDUK Oxford Neuromuscular Centre, Oxford, UK., Fischer M; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK.; MDUK Oxford Neuromuscular Centre, Oxford, UK., Wood MJA; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK.; MDUK Oxford Neuromuscular Centre, Oxford, UK., Varela MA; Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK. miguel.varela@paediatrics.ox.ac.uk.; MDUK Oxford Neuromuscular Centre, Oxford, UK. miguel.varela@paediatrics.ox.ac.uk.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2587, pp. 209-237.